MIR378D1

Across TCGA pan-cancer cohorts, MIR378D1 RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated MIR378D1 data layer.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher MIR378D1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR378D1 expression acts as an unfavorable survival marker.

UCEC, BLCA, and BRCA are the cancer types where MIR378D1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	OS	Tertile	All	0.414	0.877	<.001	108	view →
BLCA	DFS	Tertile	All	0.105	0.627	<.001	90	view →
BRCA	DFS	Tertile	All	0.833	0.950	.006	63	view →
LUAD	OS	Tertile	All	0.176	0.835	<.001	36	view →
LAML	DFS	Tertile	All	0.176	0.578	.010	36	view →
LIHC	OS	Tertile	All	0.164	0.704	.025	18	view →
THYM	OS	Tertile	All	0.712	0.971	.009	9	view →
ESCA	OS	Tertile	II,III,IV	0.446	0.709	.049	9	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

MIR378D1–UCEC (OS)

Open the UCEC breakdown →